DADATA·ANALYSIS
FREE
company · cik 1720893

BioXcel Therapeutics, Inc.

BTAINasdaqSIC 2834public
financials · annual · usd2026
Revenue$642.0K
Net income-$69.9M
Total assets$44.9M
Total liabilities$140.4M
Equity-$95.5M
LT debt$84.7M
Operating cash-$57.6M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1